<Disease><Name>CEROID LIPOFUSCINOSIS, NEURONAL, 3 (CLN3)</Name><Synonym>CLN3; BATTEN DISEASE; VOGT-SPIELMEYER DISEASE</Synonym><OMIM><Number>204200</Number><URL>http://omim.org/entry/204200</URL></OMIM><Orphanet><Number>228346</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=228346</URL></Orphanet><Protein><Number>Battenin</Number><URL>http://www.uniprot.org/uniprot/Q13286</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>16q12.1</Gene><ICD>E75.4</ICD><Summary>rare;autosomal recessive;mutation in the CLN3 gene</Summary><Symptoms><symtomp><id>3801</id><symptom>behavior, aggressive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3782</id><symptom>behavior, anxiety</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2459</id><symptom>cardiac arrhythmia, dysrhythmia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3677</id><symptom>cardiomyopathy, hypertrophic</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3460</id><symptom>cognitive impairment / cognitive dysfunction</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3165</id><symptom>dementia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3645</id><symptom>depression</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3816</id><symptom>developmental regression</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3848</id><symptom>gait disturbance</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2217</id><symptom>glaucoma</symptom><category>EYES</category></symtomp><symtomp><id>3627</id><symptom>hypokinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1958</id><symptom>psychosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1731</id><symptom>retinitis pigmentosa</symptom><category>EYES</category></symtomp><symtomp><id>2375</id><symptom>retinopathy</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4056</id><symptom>seizures, tonic clonic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2393</id><symptom>VEP (visual evoked potentials), abnormal</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>7936</id><title>The c.1A&#8201;</title><author>Kuper WFE,</author><journal>JIMD Rep</journal><year>2020</year><book /><volume>52</volume><number>1</number><pages>23-37</pages><co_aut>et al.</co_aut></literature><literature><id>6041</id><title>Timing of cognitive decline in CLN3 disease</title><author>Kuper WFE,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>41</volume><number>2</number><pages>257-261</pages><co_aut>et al.</co_aut></literature><literature><id>4547</id><title>NCLs and ER: A stressful relationship</title><author>Marotta D,</author><journal>Biochim Biophys Acta</journal><year>2017</year><book /><volume>1863</volume><number>6</number><pages>1273-1281</pages><co_aut>Tinelli E, Mole SE</co_aut></literature><literature><id>4989</id><title>Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease)</title><author>Ouseph MM,</author><journal>Ann N Y Acad Sci</journal><year>2016</year><book /><volume>1371</volume><number>1</number><pages>55-67</pages><co_aut>Kleinman ME2, Wang QJ</co_aut></literature><literature><id>5001</id><title>Human NCL Neuropathology</title><author>Radke J,</author><journal>Biochim Biophys Acta</journal><year>2015</year><book /><volume>1852</volume><number>10</number><pages>2262-2266</pages><co_aut>Stenzel W, Goebel HH</co_aut></literature><literature><id>5002</id><title>Neuronal Ceroid-Lipofuscinoses</title><author>Mole SE,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2013</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Williams RE</co_aut></literature><literature><id>4990</id><title>Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update</title><author>Rakheja D,</author><journal>Curr Mol Med</journal><year>2007</year><book /><volume>7</volume><number>6</number><pages>603-608</pages><co_aut>Narayan SB, Bennett MJ</co_aut></literature><literature><id>4991</id><title>CLN3, the protein associated with batten disease: structure, function and localization</title><author>Phillips SN,</author><journal>J Neurosci Res</journal><year>2005</year><book /><volume>79</volume><number>5</number><pages>573-583</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>